Alpheus Medical Initiates Phase 2b Trial of Investigational Therapy for Newly Diagnosed Glioblastoma

Most In-Demand Hospitality Jobs in Texas Cities - OysterLink

National Menopause Foundation Expands Board Leadership

Choose Health Launches Comprehensive At-Home GLP-1 Monitoring Panels for Ozempic, Wegovy and Mounjaro Users

NORDIC PHARMA, INC. ERREICHT MIT DER BEHANDLUNG VON 100.000 PATIENTEN EINEN WICHTIGEN MEILENSTEIN. (USA) ERWEITERT SEIN ANGEBOT UND ERHÖHT DEN BEDIENUNGSKOMFORT, INDEM ES SEINEN LIEFERUNGEN VON LACRIFILL® KANALIKULÄRES GEL ZUR BEHANDLUNG TROCKENER AUGEN BEILEGT

MARKING MAJOR MILESTONE OF 100,000 PATIENTS TREATED, NORDIC PHARMA, INC. (U.S.) ENHANCES ITS OFFERING AND INCREASES PROVIDER CONVENIENCE BY INCLUDING CANNULAS WITH ITS SHIPMENTS OF LACRIFILL® CANALICULAR GEL FOR TREATMENT OF DRY EYE SYMPTOMS

MARQUANT L'ÉTAPE IMPORTANTE DES 100 000 PATIENTS TRAITÉS, NORDIC PHARMA, INC. (U.S.) ÉLARGIT SON OFFRE ET AUGMENTE LA COMMODITÉ POUR LES PRESTATAIRES EN INCLUANT DES CANULES DANS SES LIVRAISONS DE GEL CANALICULAIRE LACRIFILL® POUR LE TRAITEMENT DES SYMPTÔMES DE LA SÉCHERESSE OCULAIRE.

Nancy L. Lewis, MD, MBS, FACP, Named New Chief Scientific Officer for National Comprehensive Cancer Network (NCCN)

Jazz Pharmaceuticals to Present Research on Epidiolex® (cannabidiol) and Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution at the 2026 American Academy of Neurology Annual Meeting

Metro Health Care Costs Vary by More than Twofold Nationwide

Glenmark Pharmaceuticals Receives U.S. FDA Approval for Progesterone Vaginal Inserts, 100 mg

RO OFFERS ELI LILLY'S FOUNDAYO™, THE NEWEST GLP-1 INNOVATION

Lodging Dynamics Launches Next-Generation Commercial Strategy with the Appointment of CCO Kristie Byrd

Regen Therapy Partners with Stealth Health to Bring Specialized Telemedicine Services and Longevity Programs to 3,000 Clinics--Powered by an Exclusive Scientific and Biologics Strategic Collaboration with ZEO ScientifiX

For Women Managing Nighttime Incontinence, Better Sleep and Comfort Start with BD® PureWick® Urine Collection System

Foundayo™ (orforglipron), Lilly's new oral GLP-1 pill for weight loss, now available in the U.S.

Avalon Healthcare Solutions Recognized as USA TODAY Top Workplace

West to Host First-Quarter 2026 Conference Call

Taiwan-Based Towards Buddha Co., Ltd. Showcases Medical-Grade TPU Tubing Injection Solutions at Medtec Japan 2026

GTCR Completes Acquisition of Zentiva, a Leading European Generics Pharmaceutical Company

Global Fine Chemicals Market Trends 2026-2036: Regional Growth Strategies from Sumitomo Chemical to IPCA Laboratories | Future Market Insights, Inc.

World's First CAR-T Therapy for Solid Tumors Available in China Soon

Bielat Santore & Company Celebrates 45 Years as New Jersey's Premier Restaurant and Hospitality Real Estate Brokerage with Special Anniversary Podcast Launch

Pacific Mind Health Releases Free De-Escalation Guide to Help People Manage Emotional Triggers in the Moment

Vanda Pharmaceuticals Announces Participation at May 2026 Investor Conferences

Ferrovial kicks off 2026 with robust operating results

COREWELL HEALTH EAST TEAMSTERS TO PRACTICE PICKET AT SOUTHFIELD CAMPUS

The Agencies Building Pharma's Next Decade Just Picked Their Software: Daily Command Launches With 18 of the Industry's Most Senior Agency Leaders Already Inside It

The Physician Who Walked Away From Medicine to Rebuild It: How Harshit Jain Spent Eight Years Asking the One Question Pharma Could Not Answer

Measured Wellness MSO names Melissa Grady Dias as Chief Executive Officer